Trial Profile
Comparison of efficacy of botulin toxin in women with de novo overactive bladder and idiopathic overactive bladder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Feb 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 23 Feb 2017 New trial record
- 01 Mar 2016 Primary endpoint of complete dryness measured at 12 weeks has not been met, according to results published in the International Urogynecology Journal.
- 01 Jun 2014 Recruitment competed according to according to results published in the International Urogynecology Journal.